Atıf Formatları
Development of curcumin and docetaxel co-loaded actively targeted PLGA nanoparticles to overcome blood brain barrier
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

I. Seko Et Al. , "Development of curcumin and docetaxel co-loaded actively targeted PLGA nanoparticles to overcome blood brain barrier," JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.66, 2021

Seko, I. Et Al. 2021. Development of curcumin and docetaxel co-loaded actively targeted PLGA nanoparticles to overcome blood brain barrier. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.66 .

Seko, I., TONBUL, H., Tavukcuoglu, E., Sahin, A., Akbas, S., Yanik, H., ... ÖZTÜRK, S. C.(2021). Development of curcumin and docetaxel co-loaded actively targeted PLGA nanoparticles to overcome blood brain barrier. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.66.

Seko, Indrit Et Al. "Development of curcumin and docetaxel co-loaded actively targeted PLGA nanoparticles to overcome blood brain barrier," JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.66, 2021

Seko, Indrit Et Al. "Development of curcumin and docetaxel co-loaded actively targeted PLGA nanoparticles to overcome blood brain barrier." JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.66, 2021

Seko, I. Et Al. (2021) . "Development of curcumin and docetaxel co-loaded actively targeted PLGA nanoparticles to overcome blood brain barrier." JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.66.

@article{article, author={Indrit Seko Et Al. }, title={Development of curcumin and docetaxel co-loaded actively targeted PLGA nanoparticles to overcome blood brain barrier}, journal={JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY}, year=2021}